Washington, D.C. 20549


Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Cassidy Meghan

(Last) (First) (Middle)


(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
3. Issuer Name and Ticker or Trading Symbol
Corteva, Inc. [ CTVA ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
See Remarks
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 26,342.3236(1) D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Non-Qualified Stock Options(2) (3) 02/02/2026 Common Stock 19,673 26.76 D
Non-Qualified Stock Options(2) (4) 02/01/2027 Common Stock 19,792 34.68 D
Non-Qualified Stock Options(2) (5) 02/14/2028 Common Stock 8,624 41.94 D
Explanation of Responses:
1. On June 1, 2019, the Reporting Person received a dividend of one (1) share of Corteva, Inc. common stock for every three (3) shares of DowDuPont Inc. held by the Reporting Person, and the Reporting Person's equity awards denominated in DowDuPont common stock were adjusted, in part, into equity awards denominated in Corteva common stock, all as described in Corteva's Registration Statement on Form 10 filed with the Securities and Exchange Commission on May 6, 2019. This amount includes restricted stock units and related dividend equivalent units.
2. In connection with the separation, certain outstanding DowDuPont stock options were converted into awards of options to purchase shares of the Issuer's common stock. The number of shares and exercise prices of each option award were adjusted in a manner intended to preserve the economic/intrinsic value of the original DowDuPont stock option.
3. This option is fully vested and exercisable.
4. 13,194 options are vested and exercisable. The remaining options will vest on February 2, 2020.
5. 2,874 options are vested and exercisable. The remaining options will vest in two equal installments on February 15, 2020 and February 15, 2021.
Senior Vice President, Chief Human Resources Officer
/s/Robert Hahm, attorney-in-fact 06/10/2019
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
                               POWER OF ATTORNEY

       The  undersigned  hereby constitutes and appoints each of Cornel Fuerer,

Robert Hahm and Abigail Jarrell, or either of them acting singly and with full
power of
substitution, as the undersigned's true and lawful attorney-in-fact to:

       (1)    execute   for and on behalf of the undersigned, in the
              capacity as an officer and/or director of Corteva, Inc. (the
              Forms 3, 4, and 5 (and any amendments thereto) in accordance with
              Section 16(a) of the Securities Exchange Act of 1934, as amended
              the "Exchange Act"), and the rules thereunder;

       (2)    do  and  perform  any  and  all  acts  for  and  on  behalf of the
              undersigned  that  may  be  necessary or desirable to complete and
              execute  any  such  Form  3,  4,  or  5,  complete and execute any
              amendments  thereto, and timely file such form with the U.S.
              and Exchange Commission (the "SEC") and any securities exchange or

              similar authority, including without limitation the execution and
              filing of a Form ID or any other documents necessary or
              to obtain codes and passwords to enable the undersigned to file
              Forms 3, 4 and 5 electronically with the SEC; and

       (3)    take  any  other  action in connection with the foregoing that, in
              the opinion of such attorney-in-fact, may be of beneift to, in the

              best interest of, or legally required by or for, the undersigned,
              it being understood that the documents executed by such attorney-
              in-fact on behalf of the undersigned pursuant to this power of
              attorney shall be in such form and shall contain such information
              and disclosure as such attorney-in-fact may approve in such
              in-fact's discretion.

       The  undersigned  hereby  grants  to such attorney-in-fact full power and
 authority  to  do and perform any and every act and thing whatsoever required,
 necessary, or proper to be done in the exercise of any of the rights and powers
 herein  granted,  as fully to all intents and purposes as the undersigned might
 or  could  do  if  personally  present,  with  full  power  of  substitution or
 revocation,  hereby ratifying and confirming all that such attorney-in-fact, or
 such  attorney-in-fact's  substitute or substitutes, shall lawfully do or cause
 to be done by virtue of this power of attorney and the rights and powers herein
 granted.  The undersigned acknowledges that the foregoing attorneys-in-fact, in
 serving  in  such capacity at the request and on behalf of the undersigned, are

 not assuming, nor  is  the  Company  assuming,  any  of the undersigned's
 responsibilities to comply with any provision of Section 16 of the Exchange

       This  Power  of  Attorney shall remain in full force and effect until the
 undersigned is no longer required to file Forms 3, 4, and 5 with respect to the
 undersigned's holdings of and transactions in securities issued by the Company,
 unless  earlier revoked by the undersigned in a signed writing delivered to
 of the foregoing attorneys-in-fact.

       IN  WITNESS WHEREOF, the undersigned has executed this Power of Attorney
 of this 17th day of April, 2019.

Signed and acknowledged:

   /s/ Meghan Cassidy
   Meghan Cassidy